期刊文献+

人Notch受体胞内区基因N2ICD克隆及真核表达 被引量:1

Cloning and eukaryotic expression of human Notch2 intracellular domain
原文传递
导出
摘要 目的构建真核重组质粒N2ICD/p CMV-Tag4并转染HEK 293T细胞进行表达。方法根据GenBank上Notch2的NICD序列设计引物,采用逆转录聚合酶链反应(RT-PCR)的方法从人宫颈癌细胞Hela细胞扩增人Notch2受体胞内区基因(N2ICD),酶切和测序鉴定后克隆至携带FLAG标签的真核表达载体pCMV-Tag4并进行瞬时和稳定转染HEK 293T细胞,荧光定量PCR(Q-PCR)和蛋白印迹(WB)检测目的蛋白的表达。结果通过RT-PCR克隆获得人N2ICD基因并成功构建重组质粒N2ICD/pCMV-Tag4,目的蛋白N2ICD在HEK 293T细胞中获得表达。结论成功构建稳定表达N2ICD的HEK 293T细胞株,为进一步探讨Notch2受体的功能奠定基础。 Objective To construct a recombinant eukaryotic expression plasmid N2ICD / pCMV-Tag4 and transfect it into HEK 293 T cells. Methods Human Notch2 intracellular domain gene( N2ICD) from Hela cells was amplified by reverse transcription-PCR( RT-PCR) and identified by enzyme restriction,sequencing and blasting and then cloned into eukaryotic expression vector pCMV-Tag4 to construct N2ICD / pCMV-Tag4,which was then transiently and stably transfected into HEK 293 T cells. Quantitative-PCR( Q-PCR) and Western blot was used to detect target protein expression.Results N2ICD was obtained by RT-PCR. The recombinant eukaryotic expression vector Notch2 intracellular domain( N2ICD) /p CMV-Tag4 was successfully constructed and N2ICD was expressed in HEK 293 T cells. Conclusion N2ICD was expressed in HEK 293 T cells,which provides a foundation for further investigating the function of Notch2 receptor.
出处 《中国公共卫生》 CAS CSCD 北大核心 2016年第3期310-314,共5页 Chinese Journal of Public Health
基金 国家高技术研究发展技术(863计划)(2014AA020909) 国家自然科学基金-广东省联合基金(U1401223) 国家自然科学基金面上项目(81470831) 广东省创新载体建设项目(2013B090800036)
关键词 Notch2信号通路 N2ICD 真核表达 pCMV-Tag4 Notch2 signaling pathway Notch2 intracellular domain eukaryotic expression pCMV-Tag4
  • 相关文献

参考文献5

二级参考文献29

  • 1Soomin Ahn,Jiyeon Hyeon,Cheol-Keun Park.Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2013,12(3):286-294. 被引量:13
  • 2AI-GuoWANG,TAOXIA,QI-LONGCHU,MINGZHANG,FANGLIU,XUE-MINCHEN,KE-DIYANG.Effects of Fluoride on Lipid Peroxidation, DNA Damage and Apoptosis in Human Embryo Hepatocytes[J].Biomedical and Environmental Sciences,2004,17(2):217-222. 被引量:18
  • 3王炯.TGF-β的生物学效应及其在某些疾病中的作用[J].国外医学(免疫学分册),1995,18(1):18-21. 被引量:11
  • 4王连方.氟斑牙的几种“Dean氏分类法”浅析[J].地方病通报,2007,22(1):71-73. 被引量:44
  • 5Score J, Calasanz MJ, Ottman O, et al. Analysis of geneomic breakpoints in p190 and p210 BCR-ABL indicate distinct mecha- nisms of formation [J]. Leukemia, 2010, 24 (10) : 1742-1750.
  • 6Deininger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia [J]. Blood, 2000, 96 (10): 3343-3356.
  • 7Yin DD, Fan FY, Hu XB, et al. Notch signaling inhibits the growth of the human chronic myeloid leukemia cell line K562 [J]. Leuk Res, 2009, 33 (1): 109-114.
  • 8Ishiko E, Matsumura I, Ezoe S, et al. Notch signals inhibit the development of erythroid / megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1 [J]. J Biol Chem, 2005, 280 (6): 4929-4939.
  • 9Gibb DR, EI Shikh M, Kang DJ, et al. ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo [J]. J Exp Med, 2010, 207 (3): 623-635.
  • 10Hubmann R, Duchler M, Sehnabl S, et al. NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells [J]. Br J Haematol, 2010, 148 (6): 868- 878.

共引文献22

同被引文献20

  • 1Andersson E R, Sandberg R, Lendahl U. Notch signaling : simplici- ty in design, versatility in function [J]. Development, 2011,138 (17) :3593 - 3612.
  • 2Wu G, Wilson G, George J, et al. Modulation of Notch signaling as a therapeutic approach for liver cancer [J]. Curr Gene Ther,2015,15 (2) :171 -181.
  • 3Andersson E R, Lendahl U. Therapeutic modulation of Notch sig- nalling- are we there yet? [J]. Nat Rev Drug Discov,2014,13 (5) :357 -378.
  • 4Chu D,Zheng J,Wang W,et al. Notch2 expression is decreased in coloreetal cancer and related to tumor differentiation status [J]. Ann Surg Onco1,2009,16 ( 12 ) :3259 - 3266.
  • 5Truong M, Cook M R, Pinchot S N, et al. Resveratrol induces Notch2 - mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer[J]. Ann Surg Oncol,2011,18 (5) :1506 - 1511.
  • 6Lee J, Sehrawat A, Singh S V. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells[J]. Breast Cancer Res Treat,2012,136( 1 ) :45 - 56.
  • 7Kim S H,Sehrawat A, Singh S V. Notch2 activation by benzyl iso- thiocyanate impedes its inhibitory effect on breast cancer cell migration [J]. Breast Cancer Res Treat,2012,134 ( 3 ) : 1067 - 1079.
  • 8Sehrawat A, Sakao K,Singh S V. Notch2 activation is protective a gainst anticancer effects of zerumbone in human breast cancer cells [J]. Breast Cancer Res Treat ,2014,146 (3) :543 -555.
  • 9Kopan R, Ilagan M X. The canonical Notch signaling pathway : un- folding the activation mechanism [J]. Cell, 2009, 137 ( 2 ) : 216 -233.
  • 10Artavanis - Tsakonas S, Rand M D, Lake R J. Notch signaling: cell fate control and signal integration in development [J]. Sci- ence, 1999,284 (5415) :770 - 776.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部